SAGE - Sage Therapeutics GAAP EPS of -$0.55 beats by $0.76 revenue of $77.97M beats by $16.99M February, 14 2024 06:33 AM Sage Therapeutics Inc. 2024-02-14 06:33:52 ET More on Sage Therapeutics Sizing Up Sage Therapeutics Biogen, Sage launch depression therapy in the U.S. Seeking Alpha’s Quant Rating on Sage Therapeutics Historical earnings data for Sage Therapeutics Financial information for Sage Therapeutics For further details see: Sage Therapeutics GAAP EPS of -$0.55 beats by $0.76, revenue of $77.97M beats by $16.99M